Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PEPTIDE-1 7-36 AMIDE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 95 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Duhlmeier, R; Deegen, E; Fuhrmann, H; Widdel, A; Sallmann, HP
      Glucose-dependent insulinotropic polypeptide (GIP) and the enteroinsular axis in equines (Equus caballus)

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR AND INTEGRATIVE PHYSIOLOGY
    2. Vara, E; Arias-Diaz, J; Garcia, C; Balibrea, JL; Blazquez, E
      Glucagon-like peptide-1(7-34) amide stimulates surfactant secretion in human type II pneumocytes

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    3. Guenifi, A; Ahren, B; Abdel-Halim, SM
      Differential effects of glucagon-like peptide-1 (7-36)amide versus cholecystokinin on arginine-induced islet hormone release in vivo and in vitro

      PANCREAS
    4. Parkes, D; Jodka, C; Smith, P; Nayak, S; Rinehart, L; Gingerich, R; Chen, K; Young, A
      Pharmacokinetic actions of exendin-4 in the rat: Comparison with glucagon-like peptide-1

      DRUG DEVELOPMENT RESEARCH
    5. Moro, F; Levenez, F; Durual, S; Plaisancie, P; Thim, L; Giraud, AS; Cuber, JC
      Secretion of the trefoil factor TFF3 from the isolated vascularly perfusedrat colon

      REGULATORY PEPTIDES
    6. Lovshin, J; Estall, J; Yusta, B; Brown, TJ; Drucker, DJ
      Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling

      JOURNAL OF BIOLOGICAL CHEMISTRY
    7. Ranganath, LR; Beety, JM; Wright, J; Morgan, LM
      Nutrient regulation of post-heparin lipoprotein lipase activity in obese subjects

      HORMONE AND METABOLIC RESEARCH
    8. Drucker, DJ
      Minireview: The glucagon-like peptides

      ENDOCRINOLOGY

    9. Novel N-substituted-2-cyanopyrrolidines as potent inhibitors of dipeptidylpeptidase IV in the treatment of non-insulin-dependent diabetes mellitus

      EXPERT OPINION ON THERAPEUTIC PATENTS
    10. Hedetoft, C; Sheikh, SP; Larsen, S; Holst, JJ
      Effect of glucagon-like peptide 1(7-36)amide in insulin-treated patients with diabetes mellitus secondary to chronic pancreatitis

      PANCREAS
    11. O'Harte, FPM; Mooney, MH; Lawlor, A; Flatt, PR
      N-terminally modified glucagon-like peptide-1(7-36) amide exhibits resistance to enzymatic degradation while maintaining its antihyperglycaemic activity in vivo

      BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
    12. Katschinski, M
      Nutritional implications of cephalic phase gastrointestinal responses

      APPETITE
    13. de Fonseca, FR; Navarro, M; Alvarez, E; Roncero, I; Chowen, JA; Maestre, O; Gomez, R; Munoz, RM; Eng, J; Blazquez, E
      Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats

      METABOLISM-CLINICAL AND EXPERIMENTAL
    14. Yip, RGC; Wolfe, MM
      GIP biology and fat metabolism

      LIFE SCIENCES
    15. Siegel, EG; Seidenstucker, A; Gallwitz, B; Schmitz, F; Reinecke-Luthge, A; Kloppel, G; Folsch, UR; Schmidt, WE
      Insulin secretion defects in liver cirrhosis can be reversed by glucagon-like peptide-1

      JOURNAL OF ENDOCRINOLOGY
    16. Lugari, R; Dell'Anna, C; Ugolotti, D; Dei Cas, A; Barilli, AL; Zandomeneghi, R; Marani, B; Lotti, M; Orlandini, A; Gnudi, A
      Effect of nutrient ingestion on glucagon-like peptide 1 (7-36 amide) secretion in human type 1 and type 2 diabetes

      HORMONE AND METABOLIC RESEARCH
    17. Moro, F; Levenez, F; Nemoz-Gaillard, E; Pellissier, S; Plaisancie, P; Cuber, JC
      Release of guanylin immunoreactivity from the isolated vascularly perfusedrat colon

      ENDOCRINOLOGY
    18. Fritsche, A; Stefan, N; Hardt, E; Haring, H; Stumvoll, M
      Characterisation of beta-cell dysfunction of impaired glucose tolerance: Evidence for impairment of incretin-induced insulin secretion

      DIABETOLOGIA
    19. Scrocchi, LA; Hill, ME; Saleh, J; Perkins, B; Drucker, DJ
      Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action

      DIABETES
    20. Brynes, AE; Edwards, CM; Jadhav, A; Ghatei, MA; Bloom, SR; Frost, GS
      Diet-induced change in fatty acid composition of plasma triacylglycerols is not associated with change in glucagon-like peptide 1 or insulin sensitivity in people with type 2 diabetes

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    21. Jackson, KG; Zampelas, A; Knapper, JME; Roche, HM; Gibney, MJ; Kafatos, A; Gould, BJ; Wright, JW; Williams, CM
      Differences in glucose-dependent insulinotrophic polypeptide hormone and hepatic lipase in subjects of southern and northern Europe: implications forpostprandial lipemia

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    22. Holst, JJ
      Glucagon-like peptide 1 (GLP-1): An intestinal hormone, signalling nutritional abundance, with an unusual therapeutic potential

      TRENDS IN ENDOCRINOLOGY AND METABOLISM
    23. Hassan, M; Eskilsson, A; Nilsson, C; Jonsson, C; Jacobsson, H; Refai, E; Larsson, S; Efendic, S
      In vivo dynamic distribution of I-131-glucagon-like peptide-1 (7-36) amidein the rat studied by gamma camera

      NUCLEAR MEDICINE AND BIOLOGY
    24. Barragan, JM; Eng, J; Rodriguez, R; Blazquez, E
      Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    25. Siegel, EG; Gallwitz, B; Scharf, G; Mentlein, R; Morys-Wortmann, C; Folsch, UR; Schrezenmeir, J; Drescher, K; Schmidt, WE
      Biological activity of GLP-1-analogues with N-terminal modifications

      REGULATORY PEPTIDES
    26. Toft-Nielsen, MB; Madsbad, S; Holst, JJ
      Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients

      DIABETES CARE
    27. Claustre, J; Brechet, S; Plaisancie, P; Chayvialle, JA; Cuber, JC
      Stimulatory effect of beta-adrenergic agonists on ileal L cell secretion and modulation by alpha-adrenergic activation

      JOURNAL OF ENDOCRINOLOGY
    28. Holz, GG; Leech, CA; Heller, RS; Castonguay, M; Habener, JF
      cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells - A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37)

      JOURNAL OF BIOLOGICAL CHEMISTRY
    29. Sandhu, H; Wiesenthal, SR; MacDonald, PE; McCall, RH; Tchipashvili, V; Rashid, S; Satkunarajah, M; Irwin, DM; Shi, ZQ; Brubaker, PL; Wheeler, MB; Vranic, M; Efendic, S; Giacca, A
      Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs

      DIABETES
    30. Long, SJ; Sutton, JA; Amaee, WB; Giouvanoudi, A; Spyrou, NM; Rogers, PJ; Morgan, LV
      No effect of glucagon-like peptide-1 on short-term satiety and energy intake in man

      BRITISH JOURNAL OF NUTRITION
    31. BRYNES AE; FROST GS; EDWARDS MB; GHATEL MA; BLOOM SR
      PLASMA GLUCAGON-LIKE PEPTIDE-1(7-36) AMIDE (GLP-1) RESPONSE TO LIQUID-PHASE, SOLID-PHASE, AND MEALS OF DIFFERING LIPID-COMPOSITION

      Nutrition
    32. FEHMANN HC; PRACHT A; GOKE B
      HIGH-LEVEL EXPRESSION OF THE GLP-I RECEPTOR RESULTS IN RECEPTOR DESENSITIZATION

      Pancreas
    33. PERFETTI R; BARNETT PS; MATHUR R; EGAN JM
      NOVEL THERAPEUTIC STRATEGIES FOR THE TREATMENT OF TYPE-2 DIABETES

      Diabetes/metabolism reviews
    34. OHARTE FPM; ABDELWAHAB YHA; CONLON JM; FLATT PR
      AMINO-TERMINAL GLYCATION OF GASTRIC-INHIBITORY POLYPEPTIDE ENHANCES ITS INSULINOTROPIC ACTION ON CLONAL PANCREATIC B-CELLS

      Biochimica et biophysica acta (G). General subjects
    35. WETTERGREN A; WOJDEMANN M; HOLST JJ
      THE INHIBITORY EFFECT OF GLUCAGON-LIKE PEPTIDE-1 (7-36)AMIDE ON ANTRAL MOTILITY IS ANTAGONIZED BY ITS N-TERMINALLY TRUNCATED PRIMARY METABOLITE GLP-1 (9-36)AMIDE

      Peptides (New York, N.Y. 1980)
    36. WETTERGREN A; PRIDAL L; WOJDEMANN M; HOLST JJ
      AMIDATED AND NON-AMIDATED GLUCAGON-LIKE PEPTIDE-1 (GLP-1) - NONPANCREATIC EFFECTS (CEPHALIC PHASE ACID-SECRETION) AND STABILITY IN PLASMA IN HUMANS

      Regulatory peptides
    37. TODD JF; EDWARDS CMB; GHATEI MA; MATHER HM; BLOOM SR
      SUBCUTANEOUS GLUCAGON-LIKE PEPTIDE-I IMPROVES POSTPRANDIAL GLYCEMIC CONTROL OVER A 3-WEEK PERIOD IN PATIENTS WITH EARLY-TYPE-2 DIABETES

      Clinical science
    38. Edwards, CMB; Todd, JF; Ghatei, MA; Bloom, SR
      Subcutaneous glucagon-like peptide-I (7-36) amide is insulinotropic and can cause hypoglycaemia in fasted healthy subjects

      CLINICAL SCIENCE
    39. SCHIRRA J; STURM K; LEICHT P; ARNOLD R; GOKE B; KATSCHINSKI M
      EXENDIN(9-39)AMIDE IS AN ANTAGONIST OF GLUCAGON-LIKE PEPTIDE-1(7-36)AMIDE IN HUMANS

      The Journal of clinical investigation
    40. DAMHOLT AB; BUCHAN AMJ; KOFOD H
      GLUCAGON-LIKE-PEPTIDE-1 SECRETION FROM CANINE L-CELLS IS INCREASED BYGLUCOSE-DEPENDENT INSULINOTROPIC PEPTIDE BUT UNAFFECTED BY GLUCOSE

      Endocrinology
    41. CORDIERBUSSAT M; BERNARD C; LEVENEZ F; KLAGES N; LASERRITZ B; PHILIPPE J; CHAYVIALLE JA; CUBER JC
      PEPTONES STIMULATE BOTH THE SECRETION OF THE INCRETIN HORMONE GLUCAGON-LIKE PEPTIDE-1 AND THE TRANSCRIPTION OF THE PROGLUCAGON GENE

      Diabetes
    42. DEACON CF; HUGHES TE; HOLST JJ
      DIPEPTIDYL-PEPTIDASE-IV INHIBITION POTENTIATES THE INSULINOTROPIC EFFECT OF GLUCAGON-LIKE PEPTIDE-1 IN THE ANESTHETIZED PIG

      Diabetes
    43. SCROCCHI LA; MARSHALL BA; COOK SM; BRUBAKER PL; DRUCKER DJ
      IDENTIFICATION OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ACTIONS ESSENTIAL FOR GLUCOSE-HOMEOSTASIS IN MICE WITH DISRUPTION OF GLP-1 RECEPTOR SIGNALING

      Diabetes
    44. DRUCKER DJ
      GLUCAGON-LIKE PEPTIDES

      Diabetes
    45. LANKATBUTTGEREIT B; GOKE B
      CLONING AND CHARACTERIZATION OF THE 5'-FLANKING SEQUENCES (PROMOTER REGION) OF THE HUMAN GLP-1 RECEPTOR GENE

      Peptides
    46. NAUCK MA; NIEDEREICHHOLZ U; ETTLER R; HOLST JJ; ORSKOV C; RITZEL R; SCHMIEGEL WH
      GLUCAGON-LIKE PEPTIDE-1 INHIBITION OF GASTRIC-EMPTYING OUTWEIGHS ITS INSULINOTROPIC EFFECTS IN HEALTHY HUMANS

      American journal of physiology: endocrinology and metabolism
    47. ROWLAND NE; CREWS EC; GENTRY RM
      COMPARISON OF FOS INDUCED IN RAT-BRAIN BY GLP-1 AND AMYLIN

      Regulatory peptides
    48. VANDELFT J; UTTENTHAL LO; HERMIDA OG; FONTELA T; GHIGLIONE M
      IDENTIFICATION OF AMIDATED FORMS OF GLP-1 IN RAT-TISSUES USING A HIGHLY SENSITIVE RADIOIMMUNOASSAY

      Regulatory peptides
    49. CHOU JZ; PLACE GD; WATERS DG; KIRKWOOD JA; BOWSHER RR
      A RADIOIMMUNOASSAY FOR LY315902, AN ANALOG OF GLUCAGON-LIKE INSULINOTROPIC PEPTIDE, AND ITS APPLICATION IN THE STUDY OF CANINE PHARMACOKINETICS

      Journal of pharmaceutical sciences
    50. TODD JF; WILDING JPH; EDWARDS CMB; KHAN FA; GHATEI MA; BLOOM SR
      GLUCAGON-LIKE PEPTIDE-1 (GLP-1) - A TRIAL OF TREATMENT IN NONINSULIN-DEPENDENT DIABETES-MELLITUS

      European journal of clinical investigation
    51. AHREN B
      GLUCAGON-LIKE PEPTIDE-1((7-36))AMIDE INCREASES CYCLIC-AMP ACCUMULATION IN NORMAL ISLETS

      Pancreas
    52. MORGAN LM
      THE METABOLIC ROLE OF GIP - PHYSIOLOGY AND PATHOLOGY

      Biochemical Society transactions
    53. DEACON CF; PRIDAL L; KLARSKOV L; OLESEN M; HOLST JJ
      GLUCAGON-LIKE PEPTIDE-1 UNDERGOES DIFFERENTIAL TISSUE-SPECIFIC METABOLISM IN THE ANESTHETIZED PIG

      American journal of physiology: endocrinology and metabolism
    54. TSENG CC; BOYLAN MO; JARBOE LA; USDIN TB; WOLFE MM
      CHRONIC DESENSITIZATION OF THE GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR IN DIABETIC RATS

      American journal of physiology: endocrinology and metabolism
    55. MIKI H; NAMBA M; NISHIMURA T; MINEO I; MATSUMURA T; MIYAGAWA J; NAKAJIMA H; KUWAJIMA M; HANAFUSA T; MATSUZAWA Y
      GLUCAGON-LIKE PEPTIDE-1(7-36) AMIDE ENHANCES INSULIN-STIMULATED GLUCOSE-UPTAKE AND DECREASES INTRACELLULAR CAMP CONTENT IN ISOLATED RAT ADIPOCYTES

      Biochimica et biophysica acta. Molecular cell research
    56. BARRAGAN JM; RODRIGUEZ RE; ENG J; BLAZQUEZ E
      INTERACTIONS OF EXENDIN-(9-39) WITH THE EFFECTS OF GLUCAGON-LIKE PEPTIDE-1-(7-36) AMIDE AND OF EXENDIN-4 ON ARTERIAL BLOOD-PRESSURE AND HEART-RATE IN RATS

      Regulatory peptides
    57. GALLWITZ B; WITT M; MORYSWORTMANN C; FOLSCH UR; SCHMIDT WE
      GLP-1 GIP CHIMERIC PEPTIDES DEFINE THE STRUCTURAL REQUIREMENTS FOR SPECIFIC LIGAND-RECEPTOR INTERACTION OF GLP-1/

      Regulatory peptides
    58. TUCKER JD; DHANVANTARI S; BRUBAKER PL
      PROGLUCAGON PROCESSING IN ISLET AND INTESTINAL-CELL LINES

      Regulatory peptides
    59. NAUCK MA; SIEMSGLUSS J; ORSKOV C; HOLST JJ
      RELEASE OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1 [7-36-AMIDE]), GASTRIC-INHIBITORY POLYPEPTIDE (GIP) AND INSULIN IN RESPONSE TO ORAL GLUCOSE AFTERUPPER AND LOWER INTESTINAL RESECTIONS

      Zeitschrift fur Gastroenterologie
    60. ORSKOV C; WETTERGREN A; HOLST JJ
      SECRETION OF THE INCRETIN HORMONES GLUCAGON-LIKE PEPTIDE-1 AND GASTRIC-INHIBITORY POLYPEPTIDE CORRELATES WITH INSULIN-SECRETION IN NORMAL MAN THROUGHOUT THE DAY

      Scandinavian journal of gastroenterology
    61. HASEGAWA H; SHIROHARA H; OKABAYASHI Y; NAKAMURA T; FUJII M; KOIDE M; OTSUKI M
      ORAL GLUCOSE-INGESTION STIMULATES CHOLECYSTOKININ RELEASE IN NORMAL SUBJECTS AND PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS

      Metabolism, clinical and experimental
    62. ALVAREZ E; RONCERO I; CHOWEN JA; THORENS B; BLAZQUEZ E
      EXPRESSION OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR GENE IN RAT-BRAIN

      Journal of neurochemistry
    63. HAMPTON SM; MORGAN LM; LAWRENCE N; ANASTASIADOU T; NORRIS F; DEACON S; RIBEIRO D; ARENDT J
      POSTPRANDIAL HORMONE AND METABOLIC RESPONSES IN SIMULATED SHIFT WORK

      Journal of Endocrinology
    64. MARTIN PA; FAULKNER A
      EFFECTS OF SOMATOSTATIN-28 ON CIRCULATING CONCENTRATIONS OF INSULIN AND GUT HORMONES IN SHEEP

      Journal of Endocrinology
    65. LU F; JIN TR; DRUCKER DJ
      PROGLUCAGON GENE-EXPRESSION IS INDUCED BY GASTRIN-RELEASING PEPTIDE IN A MOUSE ENTEROENDOCRINE CELL-LINE

      Endocrinology
    66. AHREN B; SIMONSSON E; KARLSSON S
      GLUCAGON-LIKE PEPTIDE-1((7-36))AMIDE AND CYTOPLASMIC CALCIUM IN INSULIN-PRODUCING CELLS

      Acta Physiologica Scandinavica
    67. KNAPPER JME; HEATH A; FLETCHER JM; MORGAN LM; MARKS V
      GIP AND GLP-1(7-36)AMIDE SECRETION IN RESPONSE TO INTRADUODENAL INFUSIONS OF NUTRIENTS IN PIGS

      Comparative biochemistry and physiology. Part C, Pharmacology toxicology & endocrinology
    68. GOKE R; LARSEN PJ; MIKKELSEN JD; SHEIKH SP
      DISTRIBUTION OF GLP-1 BINDING-SITES IN THE RAT-BRAIN - EVIDENCE THAT EXENDIN-4 IS A LIGAND OF BRAIN GLP-1 BINDING-SITES

      European journal of neuroscience
    69. FEHMANN HC; GHERZI R; GOKE B
      REGULATION OF ISLET HORMONE GENE-EXPRESSION BY INCRETIN HORMONES

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    70. QUALMANN C; NAUCK MA; HOLST JJ; ORSKOV C; CREUTZFELDT W
      INSULINOTROPIC ACTIONS OF INTRAVENOUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1)[7-36-AMIDE] IN THE FASTING STATE IN HEALTHY-SUBJECTS

      Acta diabetologica
    71. PRIDAL L; INGWERSEN SH; LARSEN FS; HOLST JJ; ADELHORST K; KIRK O
      COMPARISON OF SANDWICH ENZYME-LINKED IMMUNOADSORBENT ASSAY AND RADIOIMMUNOASSAY FOR DETERMINATION OF EXOGENOUS GLUCAGON-LIKE PEPTIDE-1(7-36)AMIDE IN PLASMA

      Journal of pharmaceutical and biomedical analysis
    72. CALVO JC; GISOLFI CV; BLAZQUEZ E; MORA F
      GLUCAGON-LIKE PEPTIDE-1(7-36)AMIDE INDUCES THE RELEASE OF ASPARTIC-ACID AND GLUTAMINE BY THE VENTROMEDIAL HYPOTHALAMUS OF THE CONSCIOUS RAT

      Brain research bulletin
    73. JIA X; BROWN JC; MA P; PEDERSON RA; MCINTOSH CHS
      EFFECTS OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE AND GLUCAGON-LIKE PEPTIDE-I-(7-36) ON INSULIN-SECRETION

      American journal of physiology: endocrinology and metabolism
    74. QUALMANN C; NAUCK MA; HOLST JJ; ORSKOV C; CREUTZFELDT W
      GLUCAGON-LIKE PEPTIDE-1 (7-36-AMIDE) SECRETION IN RESPONSE TO LUMINALSUCROSE FROM THE UPPER AND LOWER GUT - A STUDY USING ALPHA-GLUCOSIDASE INHIBITION (ACARBOSE)

      Scandinavian journal of gastroenterology
    75. MADSEN OD; KARLSEN C; BLUME N; JENSEN HI; LARSSON LI; HOLST JJ
      TRANSPLANTABLE GLUCAGONOMAS DERIVED FROM PLURIPOTENT RAT ISLET TUMOR-TISSUE CAUSE SEVERE ANOREXIA AND ADIPSIA

      Scandinavian journal of clinical & laboratory investigation
    76. CALVO JC; YUSTA B; MORA F; BLAZQUEZ E
      STRUCTURAL CHARACTERIZATION BY AFFINITY CROSS-LINKING OF GLUCAGON-LIKE PEPTIDE-1(7-36)AMIDE RECEPTOR IN RAT-BRAIN

      Journal of neurochemistry
    77. DEACON CF; JOHNSEN AH; HOLST JJ
      DEGRADATION OF GLUCAGON-LIKE PEPTIDE-1 BY HUMAN PLASMA IN-VITRO YIELDS AN N-TERMINALLY TRUNCATED PEPTIDE THAT IS A MAJOR ENDOGENOUS METABOLITE IN-VIVO

      The Journal of clinical endocrinology and metabolism
    78. FURNSINN C; EBNER K; WALDHAUSL W
      FAILURE OF GLP-1(7-36)AMIDE TO AFFECT GLYCOGENESIS IN RAT SKELETAL-MUSCLE

      Diabetologia
    79. KOLLIGS F; FEHMANN HC; GOKE R; GOKE B
      REDUCTION OF THE INCRETIN EFFECT IN RATS BY THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR ANTAGONIST EXENDIN(9-39) AMIDE

      Diabetes
    80. LANKATBUTTGEREIT B; GOKE R; FEHMANN HC; RICHTER G; GOKE B
      MOLECULAR-CLONING OF A CDNA-ENCODING FOR THE GLP-1 RECEPTOR EXPRESSEDIN RAT LUNG

      Experimental and clinical endocrinology
    81. GOKE R; JUST R; LANKATBUTTGEREIT B; GOKE B
      GLYCOSYLATION OF THE GLP-1 RECEPTOR IS A PREREQUISITE FOR REGULAR RECEPTOR FUNCTION

      Peptides
    82. TATEISHI K; SHIMA K; FUNAKOSHI A; YASUNAMI Y; IWAMOTO N; MATSUOKA Y
      GLUCAGON-LIKE PEPTIDE-1 (GLP-1) MOLECULAR-FORMS IN HUMAN PANCREATIC ENDOCRINE TUMORS RESEMBLE THOSE IN INTESTINE RATHER THAN PANCREAS

      Diabetes research and clinical practice
    83. VALVERDE I; MORALES M; CLEMENTE F; LOPEZDELGADO MI; DELGADO E; PEREA A; VILLANUEVAPENACARRILLO ML
      GLUCAGON-LIKE PEPTIDE-1 - A POTENT GLYCOGENIC HORMONE

      FEBS letters
    84. GALLWITZ B; WITT M; PAETZOLD G; MORYSWORTMANN C; ZIMMERMANN B; ECKART K; FOLSCH UR; SCHMIDT WE
      STRUCTURE ACTIVITY CHARACTERIZATION OF GLUCAGON-LIKE PEPTIDE-1/

      European journal of biochemistry
    85. LANKATBUTTGEREIT B; GOKE R; STOCKMANN F; JIANG J; FEHMANN H; GOKE BD
      DETECTION OF THE HUMAN GLUCAGON-LIKE PEPTIDE 1(7-36) AMIDE RECEPTOR ON INSULINOMA-DERIVED CELL-MEMBRANES

      Digestion
    86. SCHMIDTLER J; DEHNE K; ALLESCHER HD; SCHUSDZIARRA V; CLASSEN M; HOLST JJ; POLACK A; SCHEPP W
      RAT PARIETAL-CELL RECEPTORS FOR GLP-1-(7-36) AMIDE - NORTHERN BLOT, CROSS-LINKING, AND RADIOLIGAND BINDING

      The American journal of physiology
    87. BARRAGAN JM; RODRIGUEZ RE; BLAZQUEZ E
      ARTERIAL BLOOD-PRESSURE AND HEART-RATE INDUCED BY GLUCAGON-LIKE PEPTIDE-1-(7-36) AMIDE IN RATS

      The American journal of physiology
    88. NAUCK MA; BUSING M; ORSKOV C; SIEGEL EG; TALARTSCHIK J; BAARTZ A; BAARTZ T; HOPT UT; BECKER HD; CREUTZFELDT W
      PRESERVED INCRETIN EFFECT IN TYPE-1 DIABETIC-PATIENTS WITH END-STAGE NEPHROPATHY TREATED BY COMBINED HETEROTOPIC PANCREAS AND KIDNEY-TRANSPLANTATION

      Acta diabetologica
    89. SCHMIDTLER J; DEHNE K; SCHUSDZIARRA V; CLASSEN M; SCHEPP W
      PERTUSSIS-TOXIN-SENSITIVE INHIBITION OF GLUCAGON-LIKE PEPTIDE 1-STIMULATED ACID PRODUCTION BY EPIDERMAL GROWTH-FACTOR AND TRANSFORMING GROWTH-FACTOR-ALPHA IN RAT PARIETAL-CELLS

      European journal of pharmacology. Molecular pharmacology section
    90. GOKE R; MCGREGOR GP; GOKE B
      AMYLIN ALTERS THE BIOLOGICAL ACTION OF THE INCRETIN HORMONE GLP-1(7-36)AMIDE

      Life sciences
    91. GOKE R; FEHMANN HC; LINN T; SCHMIDT H; KRAUSE M; ENG J; GOKE B
      EXENDIN-4 IS A HIGH POTENCY AGONIST AND TRUNCATED EXENDIN-(9-39)-AMIDE AN ANTAGONIST AT THE GLUCAGON-LIKE PEPTIDE 1-(7-36)-AMIDE RECEPTOR OF INSULIN-SECRETING BETA-CELLS

      The Journal of biological chemistry
    92. WHEELER MB; LU M; DILLON JS; LENG XH; CHEN C; BOYD AE
      FUNCTIONAL EXPRESSION OF THE RAT GLUCAGON-LIKE PEPTIDE-I RECEPTOR, EVIDENCE FOR COUPLING TO BOTH ADENYLYL-CYCLASE AND PHOSPHOLIPASE-C

      Endocrinology
    93. FEHMANN HC; GOKE R; GOKE B
      CHARACTERIZATION OF THE INTERACTION OF GLUCAGON-LIKE PEPTIDE-1(7-37) WITH GALANIN AND SOMATOSTATIN-14 AT MOUSE INSULINOMA BETA-TC1 CELLS

      Digestion
    94. NAUCK MA; KLEINE N; ORSKOV C; HOLST JJ; WILLMS B; CREUTZFELDT W
      NORMALIZATION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLUCAGON-LIKE PEPTIDE-1 (7-36 AMIDE) IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS

      Diabetologia
    95. RICHTER G; FEDDERSEN O; WAGNER U; BARTH P; GOKE R; GOKE B
      GLP-1 STIMULATES SECRETION OF MACROMOLECULES FROM AIRWAYS AND RELAXESPULMONARY-ARTERY

      The American journal of physiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/01/21 alle ore 14:16:58